The influence of comorbidities on COVID-19 outcomes has been recognized since the
earliest days of the pandemic. But establishing causality and determining underlying …

Background and aim. The review aimed to summarize advances in the topic of endocrine
diseases and coronavirus disease 2019 (COVID-19). Methods. Scientific and institutional …

Background The hematological abnormalities are assumed to be involved in the disease
progression of COVID-19. However, the actual associations between specific blood …

The COVID-19 pandemic caused by SARS-CoV-2 is associated with a lower fatality rate
than its SARS and MERS counterparts. However, the rapid evolution of SARS-CoV-2 has …

Objectives Delivery riders have been front-line workers throughout the pandemic but little is
known about their own health and safety during this time. This study explores the health and …

Currently available vaccines against severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2) are highly effective but not able to keep the coronavirus disease 2019 …

The novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes major
challenges to the healthcare system. SARS-CoV-2 infection leads to millions of deaths …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disproportionately
impacts individuals with preexisting medical co-morbidities, such as hypertension [1]. It …

Abstract The Coronavirus Disease 2019 (COVID-19) is transitioning into the endemic phase.
Nonetheless, it is crucial to remain mindful that pandemics related to infectious respiratory …

Objective To identify subgroups likely to benefit from monoclonal antibody and antiviral
therapy by evaluating the relationship between comorbidities and hospitalization among US …